Investing.com - Financial Markets Worldwide

Entera Bio shareholders approve board election and compensation proposals

Published 18/07/2025, 21:44
Entera Bio shareholders approve board election and compensation proposals
ENTX
-0.77%

Entera Bio Ltd . (NASDAQ:ENTX) held its 2025 Annual Meeting of Shareholders on Wednesday, where shareholders voted on several proposals, according to a company statement filed with the Securities and Exchange Commission.

Shareholders elected Haya Taitel to the Board of Directors for a three-year term, with 17,288,920 votes in favor, 3,069,140 against, 137,907 abstentions, and 6,197,026 broker non-votes.

The meeting included votes on compensation-related proposals. Shareholders ratified and approved revised compensation terms and a one-time grant of compensation for Chief Executive Officer and Director Miranda Toledano, with 19,524,783 votes for, 428,993 against, 542,191 abstentions, and 6,197,026 broker non-votes.

Similar compensation proposals were approved for Chief of Research & Development Dr. Gregory Burshtein (16,518,134 for, 3,435,638 against, 542,195 abstentions, and 6,197,026 broker non-votes) and Chief Financial Officer Dana Yaacov-Garbeli (19,524,779 for, 428,993 against, 542,195 abstentions, and 6,197,026 broker non-votes).

Shareholders also ratified the company’s amended and restated compensation policy for directors and officers, with 19,520,049 votes in favor, 432,623 against, 543,295 abstentions, and 6,197,026 broker non-votes. On an advisory, non-binding basis, compensation of the company’s named executive officers was approved with 19,508,920 for, 443,752 against, 543,295 abstentions, and 6,197,026 broker non-votes.

Additionally, shareholders ratified the appointment of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, as the company’s independent auditors for the fiscal year ending December 31, 2025. The vote was 26,617,578 in favor, 59,966 against, and 15,449 abstentions.

No other matters were considered or voted upon at the Annual Meeting. All information in this article is based on a company statement filed with the SEC.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.